Targeting NMNAT1 to Axons and Synapses Transforms Its Neuroprotective Potency<i>In Vivo</i>
Elisabetta Babetto(The Ohio State University Wexner Medical Center), Michael P. Coleman(University of Cambridge)
Cited by 123
Related Papers
Alzheimer’s Disease: Etiology, Neuropathology and Pathogenesis
|Exon Publications eBooks|2020|93
Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration
|bioRxiv (Cold Spring Harbor Laboratory)|2019|10
Death receptor 6 does not regulate axon degeneration and Schwann cell injury responses during Wallerian degeneration
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0